Leading mRNA Biotech Companies (Public Industry Reference Data)
TICKER MARKET CAP LINK
- MRNA $50+ Billion Moderna, Inc.
- BNTX $30+ Billion BioNTech SE
- ALNY $20+ Billion Alnylam Pharmaceuticals, Inc.
- SRPT $9+ Billion Sarepta Therapeutics, Inc.
- IONS $5+ Billion Ionis Pharmaceuticals, Inc.
- ARWR $4+ Billion Arrowhead Pharmaceuticals, Inc.
- CVAC $1.5+ Billion CureVac N.V.
- ARCT $0.4+ Billion Arcturus Therapeutics Holdings Inc.
Private Companies:
- Abogen Biosciences $817 million
- Laronde $490 million
- Normax Biomed $300 million
- Sirnaomics $270 million
- Deep Genomics $236 million
- Nutcracker Therapeutics $219 million
- VaxEquity $195 million (ICL and AstraZeneca)
- eTheRNA $60 million
- DIOSynVax $42 million (Univ. of Cambridge, GOV UK and CEPI)
- Ethris $26 million
Big Pharma active in mRNA vaccine therapeutics R&D
- AstraZeneca
- GSK
- Janssen/Johnson & Johnson
- Merck KGaA
- Merck/MSD
- Novartis
- Pfizer
- Roche
- Sanofi ($3.2 billion acquisition of Translate Bio)